# Improved Effects of MI Plus Alpha-LA in PCOS

> **NCT03422289** · NA · COMPLETED · sponsor: **Lo.Li.Pharma s.r.l** · enrollment: 37 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** myo-inositol plus folic acid
- **DIETARY_SUPPLEMENT:** myo-inositol plus folic acid plus alpha-lactalbumin

## Key facts

- **NCT ID:** NCT03422289
- **Lead sponsor:** Lo.Li.Pharma s.r.l
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-02
- **Primary completion:** 2017-10-12
- **Final completion:** 2017-12-15
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2018-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03422289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03422289, "Improved Effects of MI Plus Alpha-LA in PCOS". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03422289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*